Mitochondria-targeted cardioprotection in aldosteronism

Area of Science:

• Cardiovascular Biology
• Mitochondrial Medicine
• Pharmacology

Background:

• Chronic aldosterone/salt treatment (ALDOST) induces myocardial structural remodeling and cardiomyocyte necrosis, leading to scarring.
• Previous research suggests intramitochondrial calcium overload, oxidative stress, and mitochondrial permeability transition pore (mPTP) opening are key pathways in ALDOST-induced cell death.

Purpose of the Study:

• To validate the cardioprotective potential of mitochondria-targeted interventions against ALDOST-induced myocardial damage.
• To investigate the role of mitochondria in mediating necrotic cell death and fibrosis during ALDOST.

Main Methods:

• Male Sprague-Dawley rats received ALDOST for 4 weeks, with co-treatment of quercetin (antioxidant) or cyclosporine A (mPTP inhibitor).
• Measurements included mitochondrial calcium, oxidative stress biomarkers (8-isoprostane, H2O2), mPTP opening, total tissue calcium, and collagen volume fraction (fibrosis).
• Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay was used to assess apoptosis.

Main Results:

• ALDOST significantly increased mitochondrial oxidative stress, mPTP opening, and calcium levels, leading to a 5-fold increase in myocardial fibrosis.
• No evidence of cardiomyocyte apoptosis was detected via TUNEL assay.
• Quercetin and cyclosporine A co-treatments effectively prevented all observed ALDOST-induced pathophysiological changes.

Conclusions:

• Mitochondria are central to the mechanisms driving necrotic cell death and myocardial scarring in response to ALDOST.
• Mitochondria-targeted interventions, such as quercetin and cyclosporine A, demonstrate significant cardioprotective effects, preserving cardiac structure.